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dsRNA produced during virus infection is
a potent innate immune stimulus.
Burgess and Mohr show that the host
mRNA exonuclease Xrn1 stimulates
vaccinia virus replication by restricting
dsRNA accumulation. This reveals a role
for the host mRNA decay machinery in
regulating dsRNA accumulation and
counteracting innate anti-viral responses.
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By accelerating global mRNA decay, many viruses
impair host protein synthesis, limiting host defenses
and stimulating virus mRNA translation. Vaccinia
virus (VacV) encodes two decapping enzymes
(D9, D10) that remove protective 50 caps on mRNAs,
presumably generating substrates for degradation
by the host exonuclease Xrn1. Surprisingly, we find
VacV infection of Xrn1-depleted cells inhibits protein
synthesis, compromising virus growth. These effects
are aggravated by D9 deficiency and dependent
upon a virus transcription factor required for inter-
mediate and late mRNA biogenesis. Considerable
double-stranded RNA (dsRNA) accumulation in
Xrn1-depleted cells is accompanied by activation
of host dsRNA-responsive defenses controlled by
PKR and 20-50 oligoadenylate synthetase (OAS),
which respectively inactivate the translation initiation
factor eIF2 and stimulate RNA cleavage by RNase L.
This proceeds despite VacV-encoded PKR and
RNase L antagonists being present. Moreover, Xrn1
depletion sensitizes uninfected cells to dsRNA
treatment. Thus, Xrn1 is a cellular factor regulating
dsRNA accumulation and dsRNA-responsive innate
immune effectors.
INTRODUCTION
By modulating mature mRNA abundance, regulated mRNA
decay provides a powerful means to control gene expression
post-transcriptionally (Garneau et al., 2007; Parker and Song,
2004). While the fate of distinct eukaryotic mRNAs is typically
controlled by critical structural features, including cis-acting
genetic elements, the 30 polyadenylated tail, and the m7-GTP
cap protecting the mRNA 50 terminus, the irreversible degrada-
tion required for mRNA turnover and surveillance pathways is
catalyzed by the 50-30 exonuclease Xrn1 in a rapid, processive
manner (Arribas-Layton et al., 2013; Jonas and Izaurralde,
2013; Nagarajan et al., 2013). In addition to deadenylation-
dependent mRNA decay, where decapped messages bearing
an exposed 50 monophosphate recruit Xrn1 through interactions
with the DCP2/DCP1a/Hedls complex (Braun et al., 2012), Xrn1332 Cell Host & Microbe 17, 332–344, March 11, 2015 ª2015 Elseviedegrades 30 fragments produced by endonucleolytic cleavage
associated with mRNA quality control processes and regulates
stability of specific messages such as those containing AREs
(Stoecklin et al., 2006) or targeted by siRNAs (Orban and Izaur-
ralde, 2005). Not only does Xrn1-dependent mRNA degradation
effectively sculpt the proteome by influencing the mRNA popu-
lation available for translation both spatially and temporally,
but it also plays a significant role controlling how cells and organ-
isms respond to stress, including virus infection (Beckham and
Parker, 2008; Mohr and Sonenberg, 2012).
To thwart production of host defense molecules and stimulate
viral mRNA translation, viruses often subvert cellular mRNA
decay pathways and manipulate Xrn1 (Gaglia and Glaunsinger,
2010; Read, 2013). While some RNA viruses circumvent Xrn1
action to preserve their genomic integrity (Chapman et al.,
2014; Dougherty et al., 2011; Silva et al., 2010), others that pro-
duce m7GTP-capped mRNAs harness the mRNA exonucleolytic
powers of Xrn1 to accelerate host and viral mRNA decay
(Gaglia et al., 2012). Besides restricting host protein synthetic
capabilities by reducing mRNA abundance, accelerating viral
mRNA turnover sharpens transitions between different kinetic
classes of temporally transcribed mRNAs and shapes the viral
developmental gene expression profile (Kwong and Frenkel,
1987; Read and Frenkel, 1983). This is exemplified by mRNA
endonucleases encoded by certain herpesviruses, which pro-
duce exposed 50-monophosphate-containing RNA fragments
that are degraded by Xrn1 (Covarrubias et al., 2011; Elgadi
et al., 1999; Everly et al., 2002; Gaglia et al., 2012). Other viruses
including influenza and coronaviruses also encode mRNA endo-
nucleases (Jagger et al., 2012; Kamitani et al., 2006; Plotch et al.,
1981); however, a role for Xrn1 and the host decay machinery
has only been shown for the SARS coronavirus nsp1 (Gaglia
et al., 2012). In contrast, vaccinia virus (VacV) encodes two nudix
domain-containing polypeptides related to the cellular Dcp2
decapping enzyme that accelerate mRNA turnover (Parrish and
Moss, 2006, 2007; Parrish et al., 2007).
As large DNA viruses that replicate exclusively within the cyto-
plasm, poxviruses like VacV encode the components required
to produce capped, polyadenylated mRNAs (Moss, 2013).
A virus-encoded heterodimeric cap methyltransferase (Morgan
et al., 1984; Niles et al., 1989; Shuman et al., 1980; Venkatesan
et al., 1980) and a poly(A) polymerase (Gershon et al., 1991;
Moss et al., 1975; Nevins and Joklik, 1977) effectively mark
nascent mRNAs with structural features vital for their stability
and capacity to be translated. These mRNAs accumulate
in discrete subcellular replication compartments together withr Inc.
select host proteins, including translation initiation factors (Kat-
safanas and Moss, 2007; Walsh et al., 2008). Remarkably, the
D9 and D10 open reading frames (ORFs) encode proteins that
stimulate mRNA turnover in infected and uninfected cells and
function as decapping enzymes in vitro (Parrish and Moss,
2006, 2007; Parrish et al., 2007). While D9 is expressed early in
the viral lifecycle, D10 is expressed later, and its expression
correlates with the virus-induced suppression of host protein
synthesis (Parrish and Moss, 2006). Indeed, the kinetics of host
protein synthesis suppression was delayed in cells infected
with a D10-deficient virus, and a D10 mutant virus was attenu-
ated for virulence in mice (Liu et al., 2014; Parrish and Moss,
2006). D10 may also regulate viral gene expression since it
prefers m7GpppG over m7GpppA substrates in vitro, and the
latter are only found on intermediate and late genes (Parrish
et al., 2007). While decapped mRNAs like those produced by
D9/10 are posited targets for Xrn1, precisely how Xrn1 might
impact infected cell biology has not been investigated.
Here, we show that Xrn1 plays an unexpected role in VacV
biology, as all ongoing protein synthesis ceased in Xrn1-
depleted primary human fibroblasts infected with VacV, severely
restricting virus growth. This occurred prior to completion of
the viral lifecycle and was exacerbated by the absence of D9
decapping enzyme. Moreover, it coincided with dsRNA accu-
mulation and activation of host dsRNA-responsive defenses
controlled by PKR, which phosphorylates and inactivates the
critical translation initiation factor eIF2, and 20-50 oligoadenylate
synthetase (OAS), which stimulates rRNA cleavage by RNase
L. Significantly, Xrn1 depletion even sensitized uninfected cells
to dsRNA treatment. Thus, a key host mRNA decay enzyme,
Xrn1, is required to regulate cytoplasmic dsRNA accumulation
and signaling through critical host dsRNA-responsive innate im-
mune sensing pathways in uninfected and VacV-infected cells.
As VacV, like many viruses, encodes a dsRNA binding protein
to limit dsRNA accumulation and signaling, our work showing
the host Xrn1 functionally controls dsRNA homeostasis in
infected cells, despite the presence of a viral dsRNA binding
protein, challenges existing notions regarding the potency of
viral dsRNA antagonists. Furthermore, it establishes that a
50-30 mRNA exonuclease plays a surprising role limiting dsRNA
accumulation in infected and uninfected cell biology.
RESULTS
Inhibition of Infected Cell Protein Synthesis and VacV
Replication by Xrn1 Depletion
Although factors important for RNA metabolism and translation,
including Xrn1, were identified in a high-throughput format,
genome-wide, RNAi screen for host proteins affecting GFP-ex-
pressing VacV spread in an established, transformed cell line,
the reliance of the virus on host mRNA decay pathways for infec-
tious virus production was not further investigated (Sivan et al.,
2013). To interrogate the role of Xrn1 in productive viral growth,
normal primary human fibroblasts (NHDFs) were treated with
control non-silencing (ns) siRNA or one of two independent
Xrn1-specific siRNAs and infectious virus production quantified
by plaque assay in permissive BSC40 cells. Compared to control
ns siRNA-treated cultures, both individual Xrn1-specific siRNAs
effectively depleted Xrn1 protein levels and reduced viral repli-Cell Hocation and spread 100- to 500-fold (Figures 1A and 1B). To
address the possibility that Xrn1 depletion might interfere
with the VacV-induced suppression of host protein synthesis,
mock- and VacV-infected NHDFs were metabolically labeled
with 35S-containing amino acids and the proteins synthesized
separated by SDS-PAGE and visualized by autoradiography. In
control ns siRNA-treated cultures, the global protein synthesis
profile in mock-infected cells was effectively suppressed by
VacV infection, which resulted in high-level viral protein synthe-
sis (Figure 1C, compare lane 1 versus 5). Surprisingly, while
Xrn1 depletion had little detectable impact on protein synthesis
in mock-infected NHDFs (Figure 1C, lane 1 versus 2), it dramat-
ically reduced all protein synthesis in VacV-infected cells (lane 5
versus 6). This phenotype was dependent on viral gene expres-
sion, as it was not observed in cells infected with UV-inactivated
virus (Figure 1C, lane 3 versus 4).
As D9 and D10 decapping enzymes stimulate mRNA decay
(Parrish et al., 2007), uncapped mRNAs could accumulate
in Xrn1-depleted, VacV-infected cells and perhaps inhibit
translation or result in cell stress. To determine if either D9 or
D10 were required to globally inhibit translation in Xrn1-depleted
NHDFs, the dependence of ongoing protein synthesis on Xrn1
was examined in cells infected with a D9- (DD9) or D10-deficient
(DD10) virus. However, rather than suppressing the phenotype,
the inhibition of protein synthesis in Xrn1-depleted cells was
even more pronounced in cells infected with DD9 compared to
DD10 or WT VacV (Figures 1D and S1). Thus, while the inhibition
of protein synthesis in Xrn1-depleted, VacV-infected NHDFs
was readily observed in the absence of D9 or D10, Xrn1 and
the VacV-encoded D9 decapping enzyme showed a synthetic
genetic interaction, consistent with their participation in a com-
mon pathway (Figures 1D and S1).
The global inhibition of ongoing protein synthesis in Xrn1-
depleted cells infected with VacV is reminiscent of the cellular
response to physiological stresses achieved by inactivation
of eIF2, a critical translation initiation factor required to load
40S ribosome subunits with initiator tRNA, via phosphorylation
of S51 on its a subunit (Mohr and Sonenberg, 2012; Walsh and
Mohr, 2011). Significantly, the inhibition of protein synthesis
in Xrn1-depleted, VacV-infected cells correlated with phosphor-
ylated eIF2a accumulation (Figure 1C). While levels of phosphor-
ylated eIF2a observed in control ns siRNA-treated NHDFs
infected with DD9 or DD10 were modestly elevated compared
to WT VacV (Figure 1D, compare lanes 7 and 10 versus 4),
they were not sufficient to detectably suppress protein synthe-
sis. Moreover, phosphorylated eIF2a abundance was further
augmented in DD9- and DD10-infected cells by Xrn1 depletion
(Figure 1D, compare lane 7 versus 8 and 9; lane 10 versus 11
and 12). In all cases, the substantial increase in eIF2a phosphor-
ylation in Xrn1-depleted, VacV-infected cells was unexpected,
as VacV, like numerous viruses, encodes multiple functions
thought to prevent eIF2a phosphorylation (Walsh et al., 2013;
Walsh and Mohr, 2011).
Accumulation of Phosphorylated eIF2a Is Dependent
upon a Virus-Specific Transcription Factor in
Xrn1-Depeted Cells
To more precisely define the point in the viral lifecycle where
mRNA translation was inhibited in Xrn1-depleted cells, proteinst & Microbe 17, 332–344, March 11, 2015 ª2015 Elsevier Inc. 333
Figure 1. Inhibition of Protein Synthesis and VacV Replication by Xrn1 Depletion
(A) NHDFs were transfected with non-silencing (ns) control or one of two Xrn1-specific siRNAs (1 and 2). After 3 days, total protein was collected and Xrn1
levels analyzed by immunoblotting. Tubulin served as a loading control.
(B) NHDFs treated with siRNAs as in (A) were infected with VacV (MOI = 53 104). Infectious virus produced after 3 days was quantified by plaque assay. Means
of three independent experiments are plotted ± SEM. ** indicates p% 0.01 by paired Student’s t test compared to control siRNA-treated samples.
(C) NHDFs treated with siRNAs as in (A) were mock-infected or infected with VacV or UV-inactivated VacV (MOI = 5). At 18 hr post-infection (hpi), cells
were metabolically pulse-labeled with [35S]Met-Cys for 30 min. Total protein was collected and separated by SDS-PAGE and 35S-labeled proteins visualized
by exposing the fixed, dried gel to X-ray film. Molecular mass standards (in kDa) are shown to the right (upper panel). The same lysates were analyzed by
immunoblotting (IB) with the indicated antibodies (lower panel). PABP1 served as a loading control.
(D) As in (C), except NHDFs were infected with WT VacV or D9 (DD9)- or D10 (DD10)-deficient VacV viruses (MOI = 3). HSC70 was used as a loading control.
See also Figure S1.synthesis was analyzed by separatingmetabolically radiolabeled
proteins by SDS-PAGE at different times post-infection. Little
or no qualitative differences were detected between overall
protein banding profiles of proteins produced in VacV-infected
cells treated with control ns siRNA versus Xrn1 siRNA at all334 Cell Host & Microbe 17, 332–344, March 11, 2015 ª2015 Elsevietime points. From 9 hpi onward, however, radiolabeled VacV
proteins were readily detected, and total 35S incorporation into
proteins throughout the lane was reduced in Xrn1-depleted
cultures versus those treated with control ns siRNA (Figure 2A).
The magnitude to which protein synthesis was suppressed inr Inc.
Figure 2. Phosphorylated eIF2a Accumulation in Xrn1-Depleted Cells Correlates with Global Protein Synthesis Inhibition Late in the VacV
Lifecycle
NHDFs transfected with ns control or Xrn1-specific siRNAs were infected with VacV (MOI = 5). At the indicated times (hpi) cells were metabolically pulse-labeled
with [35S]Met-Cys for 30 min. Uninfected cells (UI) were harvested in parallel with 18 hpi samples.
(A) Total protein was isolated and separated by SDS-PAGE, and the fixed, dried gel exposed to X-ray film. Molecular mass standards (in kDa) are shown to
the right.
(B) The same lysates were immunoblotted with the indicated antibodies. Tubulin served as a loading control.
(C) RNA from NHDFs treated with the indicated siRNAs and infected as in (A) was harvested at 6 hpi and subject to RT-qPCR using primers specific for K3L, E3L,
or Xrn1 mRNAs. Each reaction product was normalized to the signal obtained using primers specific for 18S rRNA and expressed as the fold change relative to
control siRNA-treated cells. Means of three independent experiments are plotted ± SEM.Xrn1-depleted cultures versus control siRNA-treated cultures
increased progressively over time, and was greatest at 18 hpi
when the virus-imposed suppression of host protein synthesis
was strongest (Figure 2A). Analysis of these samples by
immunoblotting indicated that phosphorylated eIF2a was
more abundant in Xrn1-depleted cultures at all time points
tested, and the inhibition of protein synthesis correlated pre-
cisely with (i) phosphorylated eIF2a levels and (ii) activation of
the dsRNA-dependent eIF2a kinase PKR by phosphorylation
(Figure 2B).
As vaccinia encodes two proteins to antagonize eIF2a phos-
phorylation (Chang et al., 1992; Seo et al., 2008), one of which
is a dsRNA-binding protein that prevents PKR activation (E3L),
while the other is an eIF2a kinase pseudosubstrate (K3L), it
was puzzling that robust eIF2a phosphorylation was observed
in Xrn1-depleted cells. One possible explanation for this was a
failure to produce E3L and K3L. Figure 2B shows that E3L
is expressed at similar levels in control and Xrn1 knockdown
cells at 6 and 9 hpi, when eIF2a becomes noticeably more phos-
phorylated in knockdown cells (Figure 2B). It is therefore not an
insufficiency of this protein that is responsible for the phenotype.Cell HoIn the absence of suitable antisera available for K3L, qPCR
was performed and showed that E3L and K3L mRNAs were
expressed in Xrn1-depleted cells, exceeding those detected in
control ns siRNA-treated cultures (Figure 2C).
Having shown that infection with UV-inactivated VacV, which
delivers virion cargo into infected cells, but cannot express
viral genes, is insufficient to inhibit protein synthesis in Xrn1-
depleted cells (Figure 1C), infected NHDFs were treated with
phosphonoacetic acid (PAA) to inhibit the viral DNA-dependent
DNA polymerase. Importantly, PAA treatment prevented the
cessation of protein synthesis observed in Xrn1-depleted,
VacV-infected NHDFs, suggesting that viral DNA synthesis
or an event closely associated with viral DNA synthesis like
intermediate/late gene expression was required to trigger this
phenotype (Figure 3A). As VacV-induced inhibition of host pro-
tein synthesis is typically visible late in infection and is sup-
pressed by PAA, expression of the viral early/intermediate
gene product I3L was used to verify that the PAA-treated cells
were indeed infected and had advanced to a stage preceding
viral DNA replication (Figure 3B). To further parse the require-
ments to trigger the inhibition of VacV-infected cell proteinst & Microbe 17, 332–344, March 11, 2015 ª2015 Elsevier Inc. 335
Figure 3. Inhibition of Protein Synthesis following Xrn1 Depletion Requires a VacV-Specific Late Gene Transcription Factor
(A) NHDFs transfected with ns control or Xrn1-specific siRNAs (1 and 2) were mock-infected or infected with VacV (MOI = 5) in the presence or absence of
PAA. At 18 hpi, cells were metabolically pulse-labeled with [35S]Met-Cys for 30 min. Total protein was collected and separated by SDS-PAGE, and 35S-labeled
proteins visualized by exposing the fixed, dried gel to X-ray film. Molecular mass standards (in kDa) are shown to the right.
(B) The same lysates were also immunoblotted with the indicated antibodies. Tubulin was used as a loading control. VacV I3 (early expressed) serves as an
infection control.
(C) As in (A), except NHDFs were infected with WT VacV or an A23-deficient virus (DA23).
(D) Lysates from (C) were immunoblotted with the indicated antibodies. eIF2a was used as a loading control.synthesis by Xrn1 depletion, NHDFs were infected with a virus
deficient in the intermediate transcription factor A23 (DA23)
(Warren et al., 2012). While DA23-infected cells replicate viral
DNA, they do not express intermediate or late genes whose
transcription follows viral DNA synthesis and is absolutely
dependent upon the A23 protein. Unlike WT VacV-infected
cultures, protein synthesis proceeds and is not detectably
impaired in Xrn1-depleted NHDFs infected with DA23 (Figures
3C and 3D). This indicates that the global inhibition of trans-
lation in Xrn1-depleted, VacV-infected cells is not triggered by
viral DNA synthesis, but is instead dependent upon a specific
virus transcription factor required for the biogenesis of discrete
intermediate and late populations of VacV mRNAs. Moreover,
it is consistent with a model positing that intermediate/late
mRNAs or their protein products somehow promote eIF2a
phosphorylation and globally inhibit translation in VacV-in-
fected, Xrn1-depleted NHDFs.336 Cell Host & Microbe 17, 332–344, March 11, 2015 ª2015 ElsevieActivation of PKR and RNase L Is Restricted by Xrn1
in VacV-Infected Cells
Of the four known mammalian eIF2a kinases that control trans-
lation in response to discrete stress, PKR, PERK, and GCN2
possess documented anti-viral activity, while only one, PKR, is
encoded by an interferon-induced gene (Walsh et al., 2013).
Importantly, although the inhibition of translation in Xrn1-
depleted NHDFs infected with VacV correlated with PKR activa-
tion (Figure 2B), both PKR and PERK activities are antagonized
by VacV-encoded effectors (Walsh et al., 2013). To determine
which of these kinases might be required for eIF2a phosphoryla-
tion in Xrn1-depleted, VacV-infected NHDFs, each was depleted
by RNAi in NHDFs treatedwith control ns or Xrn1-specific siRNA.
While little detectable change in eIF2a phosphorylation was
observed in mock-infected cells, only depleting the dsRNA-acti-
vated eIF2a kinase PKR reduced phosphorylated eIF2a levels in
Xrn1-depleted, VacV-infected cells and basal phosphorylatedr Inc.
Figure 4. PKR-Dependent eIF2a Phosphorylation and RNase L-Mediated rRNA Degradation in Xrn1-Depleted Cells Infected with VacV
(A) NHDFs transfected with the indicated siRNAs were mock-infected or infected with VacV (MOI = 5). Total protein was collected at 18 hpi and analyzed by
immunoblotting with the indicated antibodies. Tubulin served as a loading control.
(B) NHDFs transfected with the indicated siRNAs were mock-infected or infected with VacV (MOI = 5). At 18 hpi, total RNA was isolated and analyzed using a
Bioanalyzer Nano LabChip. 28S and 18S rRNA bands are indicated.
(C) NHDFs transfected with the indicated siRNAs were infected as in (A). At 18 hpi, cells were metabolically pulse-labeled with [35S]Met-Cys for 30 min. Total
protein was collected and separated by SDS-PAGE, and 35S-labeled proteins visualized by exposing the fixed, dried gel to X-ray film. Molecular mass standards
(in KDa) are shown to the right (upper panel). The same lysates were also immunoblotted (IB) with the indicated antibodies (lower panel). The RNase L-specific
immunoreactive band is indicated by an arrow. Tubulin served as a loading control.
(D) Metabolically radiolabelled samples from (C) together with two additional independent replicate experiments were TCA precipitated. 35S incorporation into
newly synthesized proteins was quantified by liquid scintillation counting. Means are plotted ± SEM. * indicates p% 0.05 by paired Student’s t test compared to
Xrn1 siRNA-treated cells. See also Figures S2 and S3.eIF2a levels observed in VacV-infected, control ns siRNA-
treated NHDFs (Figure 4A). In addition, PKR activation above
basal levels present in control ns siRNA-treated cultures wasCell Horeadily detected in Xrn1-depleted NHDFs (Figure 4A). In
contrast, depletion of PERK, a distinct eIF2a kinase activated
in response to unfolded protein accumulation in the ER, didst & Microbe 17, 332–344, March 11, 2015 ª2015 Elsevier Inc. 337
not detectably reduce eIF2a phosphorylation in Xrn1-depleted
cells and acted as a negative control (Figure 4A).
Besides PKR, 20-50 OASs are also encoded by a family of inter-
feron-stimulated genes and are components of a separate arm
of host dsRNA-dependent innate defenses. The resulting 20-50
oligoadenylate chains produced by OAS in response to dsRNA
in turn selectively activate RNase L, an endonuclease that indis-
criminately cleaves mRNAs and rRNA to inactivate ribosomes
and inhibit protein synthesis (Sadler and Williams, 2008). To
determine if RNase L was activated in Xrn1-depleted NHDFs
infected with VacV, total RNA isolated from mock- versus
VacV-infected NHDFs treated with control ns or either Xrn1
siRNA was analyzed using a Bioanalyzer Nano LabChip. While
Xrn1 depletion resulted in little detectable difference in rRNA
abundance in mock-infected cells, 28S and 18S rRNA break-
down products were only detected in VacV-infected NHDFs
treated with Xrn1-specific compared to control ns siRNA (Fig-
ures 4B and S2). Thus, two dsRNA-activated innate immune
defense pathways are specifically stimulated upon VacV infec-
tion of Xrn1-depleted cells. This suggests that Xrn1 is required
to restrict the activity of both the eIF2a kinase PKR and RNase
L, which is activated by the dsRNA-responsive OAS.
To determine the relative contribution of RNase L and/or PKR
to the global inhibition of translation in Xrn1-depleted NHDFs
upon VacV infection, the capacity of RNase L or PKR knockdown
to prevent the inhibition of protein synthesis in Xrn1-depleted
cells infected with VacV was evaluated. While infected cell
protein synthesis was similar in cultures treated with control ns
siRNA or siRNAs specific for PKR or RNase L, the inhibition of
translation associated with Xrn1 knockdown was most effec-
tively suppressed by co-depletion of RNase L (Figures 4C and
4D). Furthermore, knockdown of both Xrn1 and RNase L
reduced phosphorylated eIF2a abundance compared to cul-
tures treated with Xrn1 siRNA alone (Figures 4C and 4D). Triple
depletion of Xrn1, RNase L, and PKR reduced phosphorylated
eIF2a levels to below those observed in cultures treated with
control ns siRNA, demonstrating the involvement of the eIF2a
kinase PKR (Figures 4C and 4D). This did not, however, detect-
ably augment protein synthesis beyond levels observed in Xrn1-
RNase L doubly depleted cultures. Surprisingly, co-depletion
of Xrn1 and PKR at best only modestly increased 35S-amino
acid incorporation into protein, despite its efficacy at reducing
phosphorylated eIF2a abundance below levels observed in
VacV-infected cultures treated with control ns siRNA (Figure 4C).
This likely is a consequence of sustained RNase L activation,
which destroys both mRNA and rRNA and would be expected
to restrict protein synthesis even though eIF2 activity is
preserved. Equivalent results were obtained using a different
Xrn1-specific siRNA (Figure S3). Taken together, these results
show that the observed inhibition of protein synthesis in Xrn-
depleted cells results primarily from activation of RNase L.
Control of dsRNA Accumulation in VacV-Infected
Cells by Xrn1
Since dsRNA-responsive host defense proteins were activated
in Xrn1-depleted, VacV-infected NHDFs; this suggested that
overall steady-state dsRNA levels might be greater in VacV-
infected cells. To test this possibility, control ns siRNA-treated
and Xrn1-depleted NHDFs were mock-infected or infected with338 Cell Host & Microbe 17, 332–344, March 11, 2015 ª2015 ElsevieVacV. At different times post-infection, cultures were fixed and
processed for indirect immunofluorescence using a monoclonal
antibody that specifically detects dsRNA. Unlike earlier studies
that detected dsRNA in VacV-infected cells with this antibody
(Weber et al., 2006), we visualized the fluorophore signal without
using tyramide signal amplification. By 12 hpi, cells containing
elevated levels of dsRNAwere readily detected in Xrn1-depleted
NHDFs infected with VacV versus NHDFs treated with control ns
siRNA (Figure 5A). The fraction of dsRNA-containing VacV-
infected cells increased through 18 hpi for cultures treated
with Xrn1 siRNA compared to control ns siRNA (Figure 5A).
This was confirmed by immuno-dot blotting on immobilized
cytoplasmic extracts (Figure 5B). Furthermore, dsRNA-specific
staining was consistently most intense coincident with DAPI-
staining cytoplasmic compartments (Figure 5C), suggesting
that dsRNA accumulation is occurring specifically within viral
replication compartments.
To verify that the immunoreactive signal was indeed due to
dsRNA, fixed permeabilized cells were treated with either the
single-strand-specific ribonucleases A and T1 or the dsRNA-
specific RNase III. Figure 5D shows that dsRNA immunoreac-
tivity in Xrn1-depleted NHDFs infected with VacV was insensitive
to RNase A/T1 digestion, but abolished by pre-treatment with
RNase III, indicating that this immunostaining is in fact specific
for dsRNA. Immunopurification of dsRNA revealed enrichment
for selected viral early and late mRNAs, but not two representa-
tive host mRNAs (actin, GAPDH). While this enrichment was
readily observed in preparations treated with single-strand
ribonucleases A and T1, it was eliminated upon treatment with
the dsRNA-specific nuclease RNase III (Figures 6A and 6B).
This shows that dsRNA accumulating in VacV replication com-
partments contains virus-encoded mRNAs, although we cannot
exclude the possibility that cellular mRNAs may also be repre-
sented.While overall actin andGAPDHmRNA levels remain rela-
tively constant in Xrn1-depleted, VacV-infected NHDFs, the
abundance of representative viral early mRNAs increased signif-
icantly (Figures 6C and 6D). Activation of RNase L late in infection
(Figure S2) precluded analysis of how late VacV mRNA abun-
dance is influenced by Xrn1 depletion. This is consistent with (i)
a mechanism whereby the host 50-30 mRNA exoribonuclease
Xrn1 restricts dsRNA accumulation by accelerating viral mRNA
turnover and (ii) the possibility that the dsRNA originates from
the products of overlapping VacV transcription units on opposite
DNA strands.
Regulation of the Response to Exogenous dsRNA
in Uninfected Cells by Xrn1
The accumulation of dsRNA in Xrn1-depleted NHDFs infected
with VacV raised the possibility that Xrn1 might regulate dsRNA
responsiveness in uninfected cells and naturally buffer dsRNA
accumulation. To investigate the impact of Xrn1 depletion
on dsRNA responsiveness of uninfected cells, NHDFs treated
with control ns or Xrn1-specific siRNA were transfected with
increasing amounts of synthetic poly(I:C) dsRNA, and rates of
protein synthesis were evaluated. While reductions in the inten-
sity of individual protein bands were detected in Xrn1-depleted
NHDFs exposed to 0.01–0.05 mg/ml poly(I:C) compared to
NHDFs treated with control ns siRNA, global protein synthesis
in Xrn1-depleted NHDFs exposed to poly(I:C) concentrationsr Inc.
Figure 5. Massive dsRNA Accumulation in Xrn1-Depleted Cells Infected with VacV
NHDFs transfected with the indicated siRNAs were mock-infected or infected with VacV (MOI = 5). Cells were fixed at 6, 12, and 18 hpi and stained for
immunofluorescence with J2 anti-dsRNA antibody (green). DNA was stained using DAPI (blue).
(A) Cells were visualized using fluorescence microscopy with a 203 objective.
(B) NHDFs treated with siRNAs and infected as in (A) were harvested and cell-free lysates prepared at 18 hpi. Equal volumes of lysates were dotted onto
membrane and dsRNA detected by immunoblotting (upper panel). The dsRNA signal from (B) together with two independent replicates was quantified and the
means plotted ± SEM (lower panel).
(C) Confocal image of Xrn1 siRNA-treated infected cells from (A), fixed at 18 hpi using 633 objective.
(D) Xrn1 siRNA-treated infected cells fixed at 18 hpi were treated with a mixture of single strand-specific RNase A/T1, dsRNA-specific RNase III, or buffer alone
prior to immunostaining of dsRNA.of 0.125 mg/ml and greater was significantly inhibited by poly(I:C)
compared to corresponding controls (Figure 7A). The reduction
in ongoing mRNA translation in Xrn1-depleted NHDFs in
response to poly(I:C) was mirrored by greater amounts of acti-
vated PKR and phosphorylated eIF2a compared to culturesCell Hotreated with control ns siRNA (Figure 7B). However, while rRNA
breakdown products were observed in poly(I:C)-treated cul-
tures, further increase upon Xrn1 depletion was not detected
(Figure S4). This could indicate differences in how infected
versus uninfected NHDFs respond to Xrn1 depletion or reflectst & Microbe 17, 332–344, March 11, 2015 ª2015 Elsevier Inc. 339
Figure 6. Elevated Viral mRNA Abundance
and Their Enrichment in dsRNA Isolated
from Xrn1-Depleted, VacV- Infected Cells
(A) Cell-free lysates from NHDFs transfected with
Xrn1–1 siRNA and infected with VacV (MOI = 5)
were prepared at 22 hpi and immunoprecipitated
using J2 anti-dsRNA antibody. After treating with
RNase A/T1 or RNase III, isolated RNA was
analyzed by RT-qPCR using the indicated viral or
cellular mRNA primers. mRNA abundances were
normalized to actin and calculated relative to input
(set to 1). The means of three independent ex-
periments are plotted ± SEM.
(B) Equal volumes of buffer, input lysate (IP input),
or the unbound fraction (IP unbound) were
dotted onto a membrane and dsRNA detected by
immunoblotting to demonstrate dsRNA depletion
in the unbound fraction.
(C and D) NHDFs were treated with the indicated
siRNAs and RNA isolated from uninfected cells
(C) or 3 hpi with VACV (MOI = 5) (D). RNA was
subject to RT-qPCR analysis for the indicated
cellular or early viral mRNAs and each reaction
product normalized to 18S rRNA and presented as
the fold change relative to control siRNA-treated
cells. The means of three independent experi-
ments are plotted ± SEM. A significant difference
by paired Student’s t test compared to control
siRNA-treated cells is indicated by * (p % 0.05)
or ** (p% 0.01).technical limitations in the assay. Nevertheless, the cellular 50-30
mRNA exonuclease unexpectedly can control the host response
to exogenous dsRNA, an important pathogen-associated mo-
lecular pattern capable of activating potent innate defenses, in
uninfected primary human cells.
DISCUSSION
By encoding two nudix hydrolase domain-containing proteins
with enzymatic decapping activity in vitro that share homology
to the host protein Dcp2, VacV accelerates global mRNA decay
in infected cells (Parrish and Moss, 2006, 2007; Parrish et al.,
2007). In uninfected cells, cap removal results in mRNAs
harboring a 50 monophosphate mRNA terminus that are subse-
quently degraded by the mRNA 50-30 exonuclease Xrn1 (Arri-
bas-Layton et al., 2013; Jonas and Izaurralde, 2013; Nagarajan
et al., 2013). Here, we show that VacV growth is severely
restricted in Xrn1-depleted primary human cells, as ongoing vi-
rus and host protein synthesis is inhibited. The global repression
of protein synthesis was augmented in cells infected with a D9-
deficient virus and dependent upon a specific transcription fac-
tor required for production of VacV intermediate/late mRNA.
Significantly, substantial dsRNA accumulation and activation of
host dsRNA-responsive innate defenses was observed, which
resulted in inactivation of the translation initiation factor eIF2
and RNase L-mediated rRNA cleavage. Furthermore, Xrn1
depletion unexpectedly heightened uninfected cell sensitivity
to dsRNA. This establishes a role for the host mRNA exonu-
clease Xrn1 as a potent effector limiting activation of host340 Cell Host & Microbe 17, 332–344, March 11, 2015 ª2015 ElseviedsRNA-responsive innate immune defenses by regulating
dsRNA abundance in uninfected and virus-infected cells.
The impressive increase in dsRNA accumulation in Xrn1-
depleted, VacV-infected cells was unforeseen, as Xrn1 is a
processive exonuclease whose substrate is single-stranded
mRNA with exposed 50-phosphate termini. Previous studies,
however, have shown that it is capable of processing RNA
stem loops (Decker and Parker, 1993; Poole and Stevens,
1997) and RNA:DNA duplexes (Jinek et al., 2011) provided that
the 50 RNA overhang is of sufficient length. Therefore Xrn1 may
function not only to control VacV mRNA turnover, but also
destabilize RNA duplexes and directly degrade imperfectly
annealed strands. This could require or be stimulated by an
ancillary RNA helicase to perhaps accelerate duplex unwinding.
Our finding that Xrn1-depleted cells were more sensitive to
poly(I:C)-induced PKR activation, eIF2a phosphorylation, and in-
hibition of translation is consistent with this notion, as poly(I:C)
is a heterogeneous, synthetic dsRNA analog comprised of
poly-nucleotide duplexes of varied lengths that likely contain
single-stranded overhangs capable of being processed directly
by Xrn1.
It has been argued for decades that dsRNA accumulation
in DNA virus-infected cells arises via mRNAs produced from
transcription units on opposing DNA strands, although direct
evidence for this has been scant (Aloni, 1972; Aloni and Locker,
1973; Boone et al., 1979; Jacobs and Langland, 1996; Jacque-
mont and Roizman, 1975; Lucas and Ginsberg, 1972). While
dsRNA has been isolated from infected cells and shown to acti-
vate PKR in vitro, it remained possible that such RNA structuresr Inc.
Figure 7. Increased Sensitivity to the dsRNA
Analog Poly(I:C) in Response to Xrn1 Deple-
tion in Uninfected Cells
(A and B) NHDFs treated with the indicated
siRNAs were mock-transfected or transfected with
increasing amounts of poly(I:C). After 3 hr, cells
were metabolically pulse-labeled with [35S]Met-
Cys for 30 min. Total protein was collected and
separated by SDS-PAGE, and 35S-labeled pro-
teins directly visualized by exposing the fixed,
dried gel to X-ray film. Molecular mass standards
(in KDa) are shown to the left (A). The same lysates
were also immunoblotted with the indicated anti-
bodies (B). Tubulin served as a loading control.
See also Figure S4.formed as a result of the purification process and did not natu-
rally exist as bona fide viral mRNA duplexes in infected cells
(Maran and Mathews, 1988). Furthermore, although dsRNA
has been detected by immunostaining in situ, its precise origin
remained to be determined (Weber et al., 2006). Our data that
dsRNA accumulation and activation of dsRNA-responsive host
defenses in VacV-infected cells (i) are controlled by the major
cellular mRNA exonuclease and (ii) are dependent upon a viral
transcription factor required for the biogenesis of a specific class
of mRNAs in Xrn1-depleted cells provide key biological supportCell Host & Microbe 17, 332–34for the hypothesis that dsRNA comprised
of viral mRNA duplexes activates PKR
and RNase L.
In addition to E3L, a dsRNA binding
protein that also inhibits RNase L (Chang
et al., 1992; Rivas et al., 1998), and the
eIF2a pseudosubstrate K3L (Seo et al.,
2008), we show that VacV-encoded de-
capping enzymes required to accelerate
mRNA turnover in infected cells also indi-
vidually control eIF2a phosphorylation in
infected primary human cells. In a parallel
investigation, B. Moss and colleagues
show that the combined deletion of
D9 and D10 decapping enzymes results
in dsRNA production, PKR activation,
eIF2a phosphorylation, and RNase L acti-
vation similar to our findings in Xrn1-
depleted cells (Liu et al., 2015 [this issue
of Cell Host & Microbe]). Thus, increasing
mRNA half-life may increase the probabil-
ity that a specific set of mRNAs forms
dsRNA, even with normal Xrn1 levels.
A synthetic genetic interaction was de-
tected involving D9 deficiency and Xrn1
depletion in that inhibition of translation
in VacV-infected cells was more severe
in the absence of this viral decapping
enzyme. When Xrn1 levels are reduced,
decapped mRNAs with the potential to
form dsRNA are likely further stabilized,
but cannot be efficiently utilized by
the translation machinery as they lackanm7GTP cap. Interestingly, other examples indicating a power-
ful relationship between stress-induced anti-viral responses,
including eIF2a phosphorylation, and mRNA decay have
emerged from other systems. The HSV1-encoded endoribonu-
clease vhs stimulates mRNA decay and acts together with at
least two additional viral factors to antagonize PKR in infected
cells (He et al., 1997; Mulvey et al., 2003; Read, 2013; Sciortino
et al., 2013). In contrast, overexpression of the cellular decapp-
ing complex component Dcp1a induced eIF2a phosphorylation
mediated by the protein activator PACT and restricted poliovirus4, March 11, 2015 ª2015 Elsevier Inc. 341
infection (Dougherty et al., 2011). Finally, cellular Dcp2 modu-
lates IRF7 mRNA stability, and Dcp2-deficient cells exhibit
sustained type I IFN production, which has an anti-viral effect
(Li et al., 2012).
It is remarkable that the depletion of a single host gene has
such an unprecedented impact on dsRNA accumulation and
activation of host dsRNA-responsive innate immune defenses.
While many viruses including VacV encode dsRNA binding pro-
teins or other functions to limit eIF2a phosphorylation, prevent
RNase L activation, and preserve the capacity of the cellular
translation machinery to produce viral proteins (Walsh et al.,
2013), Xrn1 represents a host factor that plays a significant
role in allowing the virus to effectively antagonize host defenses.
Since Xrn1 depletion does not prevent K3L and E3L expression,
the resulting inhibition of protein synthesis in VacV-infected
cells implies that the capacity of E3L and K3L to effectively
antagonize host defenses is dependent upon preset levels of
host factors including the cellular mRNA exonuclease Xrn1.
Perturbing the natural homeostasis of host factors like Xrn1,
which restrict dsRNA accumulation, can overwhelm the capac-
ity of viral functions to antagonize host dsRNA-responsive
innate defenses. This directly shows that viral antagonists of
PKR and RNase L evolved to function within an environmental
host context that regulates dsRNA accumulation, one compo-
nent of which is Xrn1. Somewhat paradoxically, the effective-
ness with which virus-encoded factors succeed in an ‘‘arms
race’’ to antagonize host dsRNA-responsive defenses (Daugh-
erty and Malik, 2012) is therefore reliant upon host functions
that likewise limit dsRNA accumulation. Indeed, Xrn1 was
among genes differentially expressed in high versus low re-
sponders to primary smallpox vaccination, perhaps reflecting,
in part, its role in innate responses to dsRNA (Haralambieva
et al., 2012). Moreover, it might be possible to exploit Xrn1 as
a druggable target to selectively induce dsRNA production in
acutely infected cells so that virus-encoded antagonists are
overwhelmed, and the virus is revealed to the innate immune
system.
EXPERIMENTAL PROCEDURES
Antibodies and Chemicals
Monoclonal E3L antiserum was a kind gift from S. Isaacs (University of
Pennsylvania). Polyclonal PABP1 antiserum was a kind gift of S. Morley
(University of Sussex). I3 antiserum was a kind gift of D. Evans (University of
Alberta). All other antibodies were purchased commercially as follows: Xrn1
(A300-443A; Bethyl Laboratories), a tubulin (6074; Sigma), eIF2a (5324; Cell
Signaling Technology), phospho(ser51)-eIF2a (3398; Cell Signaling Technol-
ogy), PKR (12297; Cell Signaling Technology), phospho(T446)-PKR (32036;
Abcam), PERK (5683; Cell Signaling Technology), Hsc70 (10011384; Cayman
Chemical), RNase L (13825; Abcam), dsRNA (J2; SciCons). PAA was from
Sigma.
Cells and Viruses
Primary normal human diploid fibroblasts (NHDFs; Clonetics) were propa-
gated in DMEM supplemented with 5% fetal bovine serum (FBS) plus1%
penicillin/streptomycin (v/v), routinely sub-cultured 1:3 and maintained
until passage 24. VacV (Western Reserve strain) was propagated in BSC40
cells, and virus stocks were prepared and titered as described (Walsh
et al., 2008). UV-inactivated virus was prepared by exposing 1 ml of virus
stock in a six-well dish to six pulses of 0.12 J/cm2 UV light in a Stratalinker
(Stratagene). A23, D9, and D10 viruses were supplied by B. Moss (NIH
NIAD, Bethesda).342 Cell Host & Microbe 17, 332–344, March 11, 2015 ª2015 ElsevieTransfections and Infections
One day prior to siRNA transfection, NHDF cells were seeded in a 6-well or
12-well dish at 1.6 3 105 or 8 3 104 cells per well, respectively. Cells were
transfected with siRNAs (see below) at a final concentration of 20 nM each
using Lipofectamine RNAiMax (Life Technologies) at 1.25 ml/ml according to
the manufacturer’s instructions. For double/triple combination siRNA experi-
ments the negative control siRNA was used to ensure all cells received the
same final concentration of siRNAs. Poly(I:C) transfections were conducted
3 days after siRNA transfection using poly(I:C) (Cat. No. P9582; Sigma) diluted
in Opti-MEM and Lipofectamine 2000 (Life Technologies) according to manu-
facturer’s instructions. Prior to infection of siRNA-transfected cells the media
was changed at 3 days post-transfection. Mock infections were performed
with the same media used to dilute virus stocks. Following multicycle growth
experiments, NHDF cultures were frozen at 80C, and after three freeze-
thaw cycles the amount of infectious virus was quantified by plaque assay in
BSC40 cells.
siRNAs
Xrn1 siRNA-1 was custom-generated by Genelink as a duplex with UU 30 over-
hangs with the following sequence: 50AGAUGAACUUACCGUAGAA30
(taken from Damgaard et al., 2008). All other siRNAs were commercially
sourced as follows: AllStars Negative Control (SI03650318; QIAGEN), Xrn1–
2 (SI00764127; QIAGEN), PKR (SI00042819; QIAGEN), PERK (SI02223725;
QIAGEN), RNase L (SASI_Hs01_00081000; Sigma).
Immunofluorescence
Cells were seeded onto glass coverslips, and transfected/infected cells
were fixed with 4% formaldehyde for 15 min and permeabilized with 0.5%
Triton X-100. For RNase treatments cells were incubated in RNase buffer
(10 mM Tris:HCl [pH 8.3], 10 mM MgCl2, 1 mM DTT, 60 mM NaCl) containing
50 U/ml RNase III (E6146S; New England Biolabs) or 50 ml/ml RNaseA/T1 mix
(AM2286; Ambion), reflecting 25 U/ml and 1,000 U/ml, respectively, for 15 min
at 37C. Samples were then blocked in 4% FBS, incubated with primary anti-
sera, and incubated with anti-mouse AlexaFluor 488 (A11029; Life Technolo-
gies) secondary antibody for 1 hr at room temperature. DNA was stained
with 40,60-diamidino-2-phenylindole (DAPI). The fluorescent images were
collected with a Zeiss LSM710 confocal microscope or a Zeiss Axiovert fluo-
rescence microscope, using Zen 2008 software (Zeiss).
Immuno-Dot Blotting of dsRNA
NHDFs were lysed in cytoplasmic lysis buffer (15 mM Tris [pH 7.5], 0.3 MNaCl,
15 mM MgCl2, 1% Triton X-100, 100 U/ml RNase inhibitor [Fermentas])
containing complete EDTA-free protease inhibitors (Roche) for 15 min on
ice. Samples were centrifuged for 1 min at 12,000 RCF at 4C and superna-
tants collected. Extracts (5 ml) were dotted on to PVDFmembrane and allowed
to dry. RNA was then cross-linked using two pulses of 0.125 J/cm2 UV light
in a Stratalinker (Stratagene). The membrane was then processed as for an
immunoblot. Dot blots were quantified from film using Li-Cor Image Studio
software to calculate signal intensity adjusted for background.
dsRNA Immunoprecipitation
Approximately 4 3 106 siRNA-transfected VacV-infected (MOI = 5) NHDFs
were washed twice with cold PBS on ice and lysed in 1 ml IP buffer (15 mM
Tris [pH 7.5], 0.1 M NaCl, 5 mMMgCl2, 0.5% Triton X-100, 1 mM dithiothreitol,
100 U/ml RNase inhibitor [Fermentas]) containing complete EDTA-free prote-
ase inhibitors (Roche) for 10 min on ice. Lysates were centrifuged for 1 min at
12,000 RCF at 4C and supernatant collected. This was pre-cleared with 40 ml
of protein-G+ agarose beads (25% slurry; Santa Cruz Biotechnology; SC-
2002) for 1 hr at 4C before incubation of lysate with 7 mg J2 dsRNA antibody
overnight at 4C on a rotating wheel. Lysate was then incubated with 40 ml of
protein-G+ agarose beads for 3 hr at 4C. Beads were then washed with IP
buffer four times then treated with either 20 U/ml RNase III or 20 ml/ml
RNaseA/T1 (25 U/ml/1,000 U/ml, respectively) for 15 min at 37C. Beads
were thenwashed three times and resuspended in 1ml Trizol for RNA isolation.
Bioanalyzer RNA Analysis
RNA samples were analyzed on an Agilent 2200 Bioanalyzer using RNA Nano
LabChips.r Inc.
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